申请人:SHIONOGI & CO., LTD.
公开号:EP0570594A1
公开(公告)日:1993-11-24
A novel hydroxamic acid derivative containing a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof as the active ingredient, which has activities of inhibiting cell growth, vascularization, etc.. It has activities of inhibiting hemangioendothelial cell growth and the development of a lymphocyte adhesion factor, and detransformation by ras gene, thus inhibiting cell growth and being efficacious against inflammation and tumor.
一种新型羟肟酸衍生物,其活性成分含有通式(I)代表的化合物或其药学上可接受的盐,具有抑制细胞生长、血管生成等活性。它具有抑制血液内皮细胞生长、淋巴细胞粘附因子的形成和 ras 基因的脱转化的活性,从而抑制细胞生长,对炎症和肿瘤有效。